Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
22nd Century Group (NASDAQ: XXII) pioneers plant-based solutions for tobacco harm reduction through advanced biotechnology. This news hub provides investors and stakeholders with essential updates on regulatory milestones, product innovations, and operational developments central to the company's mission of reducing nicotine addiction.
Access authoritative coverage of FDA communications, VLN product advancements, and manufacturing capacity updates. Our curated collection includes earnings reports, patent filings, and scientific research collaborations that demonstrate 22nd Century's leadership in developing reduced-nicotine tobacco products.
Key updates feature the company's Modified Risk Tobacco Product authorization, progress in international market expansion, and innovations in nicotine biosynthesis control. Regular updates ensure informed tracking of this biotechnology firm's unique position at the intersection of public health and commercial tobacco production.
Bookmark this page for streamlined access to verified corporate announcements and analysis-free reporting on 22nd Century's progress in redefining tobacco consumption through science-driven solutions.
22nd Century Group (Nasdaq: XXII) has submitted public comments supporting the FDA's proposed mandate to reduce nicotine content in cigarettes and certain combusted tobacco products. The company's submission highlights that their Very Low Nicotine Content (VLNC) technology could transform the industry within two years.
According to FDA's model, the proposed rule could prevent 48 million youth and young adults from starting smoking and avert 1.8 million tobacco-related deaths by 2060. The company's VLN® cigarettes, containing 95% less nicotine than traditional cigarettes, are currently the only FDA-authorized low nicotine combustible cigarettes in the U.S.
The initiative has received support from over 75 health care professional organizations, including the American Medical Association and American College of Cardiology, while facing opposition from major tobacco producers.
22nd Century Group (Nasdaq: XXII) has secured a $9.5 million cash settlement from insurers for business interruption claims related to the November 2022 Grass Valley incident. The settlement payment must be made within 45 days of the agreement's effective date.
The company, now debt-free, views this non-dilutive capital as crucial for growth rather than survival. CEO Larry Firestone emphasized that after addressing legacy issues over the past 22 months, the company is positioned to achieve profitability in 2026.
22nd Century Group specializes in tobacco harm reduction through its proprietary non-GMO reduced nicotine tobacco plants, which contain 95% less nicotine than traditional tobacco. Their flagship product, VLN® cigarette, is the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII) has announced a significant financial milestone by becoming debt-free after repaying its remaining $3.9 million senior secured debt following the completion of its Series A convertible preferred stock offering. The company has eliminated over $20 million in senior secured and subordinated debt under CEO Larry Firestone's leadership.
The financial restructuring has resulted in an approximate $9.1 million increase in adjusted pro forma net tangible book value ($1.05 per share). The company plans to utilize its capital to expand its very low nicotine tobacco leaf inventory in Q4 2025, with capacity to produce over 1 million cartons of VLN combustible products. The company's VLN® cigarettes, containing 95% less nicotine than traditional cigarettes, remain the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.
Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.
22nd Century Group (Nasdaq: XXII) CEO Larry Firestone provided a comprehensive update on the company's VLN® reduced nicotine tobacco products and regulatory developments. The company announced two major partnerships with Smoker Friendly and Pinnacle for VLN® product distribution, with initial Pinnacle stocking orders shipped in August 2025.
The FDA's proposed Tobacco Product Standard for Nicotine Yield, expected by September 15, 2025, could mandate a 0.7mg/g maximum nicotine content. The company is expanding its VLN® product line to include 100mm cigarettes, international versions, and filtered cigars. Additionally, research is underway exploring potential links between their non-GMO low nicotine tobacco genetics and reduced levels of harmful TSNAs (Tobacco-Specific Nitrosamines).
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms through nicotine addiction control, has announced its participation in the upcoming Emerging Growth Virtual Investor Conference.
CEO Larry Firestone and CFO Dan Otto will present on August 20, 2025 at 1:10 PM ET. Investors can register online to attend the virtual presentation and submit questions in advance. A replay will be available in the Events section of the company's IR website.
22nd Century Group (Nasdaq: XXII) reported Q2 2025 financial results, showing a revenue decline to $4.1 million from $6.0 million in Q1 2025. The company reported a net loss of $3.3 million and an Adjusted EBITDA loss of $2.6 million.
Key developments include expanded state authorizations for VLN® products (now in 44 states), partnership with Pinnacle for VLN® distribution in nearly 1,000 locations of a top-5 c-store chain, and debt reduction of $1.0 million to $3.8 million. The company's cigarette volumes increased to 594,000 cartons in Q2 2025 compared to 319,000 in Q1 2025.
The company is advancing its tobacco harm reduction strategy with its proprietary reduced nicotine content tobacco products, including development of a 100mm VLN® cigarette prototype targeting FDA submission in Q4 2025.
[ "Expanded state authorizations to 44 states for VLN® products", "Secured partnership with Pinnacle VLN® for distribution in nearly 1,000 top-5 c-store locations", "Increased cigarette carton volumes by 86% quarter-over-quarter to 594,000", "Reduced debt by $1.0 million to $3.8 million", "Advanced development of 100mm VLN® reduced nicotine cigarette prototype" ]22nd Century Group (Nasdaq: XXII) has scheduled its Second Quarter 2025 earnings conference call for August 14, 2025, at 8:00 AM ET. The company will release its financial results via press release at 6:00 AM ET the same day.
CEO Larry Firestone and CFO Dan Otto will lead the webcast, discussing quarterly results, recent developments, and outlook for 2025. The webcast will be available live and archived on the company's investor relations website.
22nd Century Group (Nasdaq: XXII) announced the initial shipments of its Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine cigarettes. The products will launch on September 1, 2025 across nearly 1,000 locations in 12 states through a top-5 U.S. convenience store chain.
The Pinnacle VLN® cigarettes contain 95% less nicotine compared to traditional cigarettes, meeting the FDA's proposed standard of less than 0.7 mg/g nicotine content. These products are the first and only FDA-authorized combusted cigarettes specifically designed to reduce nicotine intake, supported by extensive clinical research demonstrating their effectiveness in reducing smoking habits.
22nd Century Group (Nasdaq: XXII) welcomes the American Academy of Family Physicians' (AAFP) support for the FDA's proposed reduced nicotine mandate. The AAFP, representing over 128,300 family physicians, endorses establishing a maximum nicotine yield of 0.7 milligrams per gram of tobacco in combustible products.
The company's VLN® products, including partner brands Smoker Friendly VLN® and Pinnacle VLN®, are currently the only FDA-authorized reduced nicotine content cigarettes that comply with the proposed standard. According to the release, smoking causes over 480,000 deaths and costs more than $600 billion annually in the United States, while reducing life expectancy by 10 years.
FAQ
What is the current stock price of 22Nd Century (XXII)?
What is the market cap of 22Nd Century (XXII)?
